Denmark· DK-28103050698
Agenerase
A amprenavir product containing amprenavir, registered in Denmark by Glaxo Group Limited. The same ATC class is registered in 3 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Amprenavir is registered in 3 of 19 countries.
Countries holding a registration under ATC J05AE05 (amprenavir), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 1 of them publish a price we can compare per daily dose
Amprenavir · ATC J05AE05
3 / 19 countries
- Denmark
- Finlandprice
- United Kingdom
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- AMPRENAVIR
- Manufacturer
- Glaxo Group Limited
- Country
- Denmark (DK)
- ATC code
- J05AE05
- ATC class
- Amprenavir
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28103050698
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
340 interactions on record for amprenavir.
Graded by severity as the source publishes them — 129 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amprenavir · interactions on record
340 records
- 129 severe
- 194 moderate
- 16 minor
- 1 info
Most severe, free to view
- MetronidazoleA01AB17severe
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- LoperamideA07DA03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J05AE05
Amprenavir, as other registers publish it.
- FinlandAgeneraseGlaxo Group Ltd
- FinlandAgeneraseGlaxo Group Ltd
- FinlandAgeneraseGlaxo Group Ltd
- United KingdomAgenerase 150mg capsulesGlaxoSmithKline UK Ltd
- United KingdomAgenerase 15mg/ml oral solutionGlaxoSmithKline UK Ltd
- United KingdomAgenerase 15mg/ml oral solution bubblegumGlaxoSmithKline UK Ltd
- United KingdomAgenerase 15mg/ml oral solution grapeGlaxoSmithKline UK Ltd
- United KingdomAgenerase 50mg capsulesGlaxoSmithKline UK Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/895b5b26-2e69-450f-9406-dbfa4a46b82f GET /v1/drugs/895b5b26-2e69-450f-9406-dbfa4a46b82f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "kapsler, bløde",
"source": "dkma",
"strength": "150 mg",
"auth_role": "MOD",
"dk_drugid": "28103050698",
"substance": "AMPRENAVIR",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "36819"
}See everything about amprenavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.